Page 426 - Carrahers_Polymer_Chemistry,_Eighth_Edition
P. 426

Organometallic and Inorganic–Organic Polymers                                389


                 compounds generally degrade to nontoxic inorganic compounds so that they are “environmen-
                 tally friendly.” The second reason concerns the commercial availability of a wide variety of
                 organotin compounds that are suitable as monomers. Third, because of the biological activity of
                 organotin compounds they were found to inhibit the growth of desirable species, in particular,
                 in aquatic surroundings. This brought about federal laws that prohibited the use of leachable,
                 monomeric-organotin compounds in a variety of coatings and protective applications. The result
                 was a move to polymeric materials that did not suffer the same leachability and which were
                 allowed by law.
                    Much of the recent activity with organotin compounds, including polymers, involves their use
                 to inhibit a wide variety of microorganisms at low concentrations. These microorganisms include a
                 variety of cancers, bacteria, yeasts, and viruses. Carraher, Roner, Barot, and coworkers have found
                 that some simple organotin polyethers based on hydroxyl-terminated poly(ethylene glycols) inhibit
                 a wide variety of cancers, including ones associated with bone, lung, prostate, breast, and colon
                 cancers.

                                            H C    O
                                             3
                                                                     CH 3
                                               Sn                 O
                                                                 n   x                     (11.20)
                                            C
                                          H 3
                                                CH
                                                  3
                    Two measures are typically employed to measure the ability of cancer cells to grow. The fi rst
                 is the concentration needed to inhibit 50% growth of the cell line, GI . Some of these polymers
                                                                           50
                 have GI  values well below those of cisplatin, the most widely used anticancer drug. The second
                        50
                 measure is the chemotherapeutic index, CI, which is the concentration of the compound that inhibits
                 the growth of the healthy or normal cell by 50% divided by the concentration of the compound that
                 inhibits the growth of the cancer or tumor cell by 50%. Larger values are desired since they indicate
                 that a larger concentration is required to inhibit the healthy cells in comparison to the cancer cells,
                 or, stated in another way, larger values indicate some preference for inhibiting the cancer cells in
                 preference to the normal cells. Some of these polymers have CI values in the hundreds, allowing
                 healthy cells to reproduce at concentrations where cancer cell lines are inhibited. Of additional
                 interest is that some of these organotin polymers are water soluble, allowing for medical applica-
                 tions utilizing the material in simple pills.
                    A wide variety of organotin compounds developed by Carraher, Sabir, Roner, and others on
                 the basis of known antiviral drugs such as acyclovir and known-antibacterial agents such as cipro-
                 fl oxacin, norfloxacin, cephalexin (11.21), and ampicillin, inhibit a wide variety of viruses, including

                 the ones responsible for many of the common colds, chicken pox, small pox, shingles, and herpes
                 simplex.

                                                         R
                                                     NH

                                                          O


                                                      HN         S
                                                                                           (11.21)

                                                              N
                                                                        CH
                                                       O                  3
                                                            R
                                                       R     1
                                                          Sn
                                                                    O
                                                             O
                                                       R 1





                                                                                              9/14/2010   3:41:39 PM
         K10478.indb   389
         K10478.indb   389                                                                    9/14/2010   3:41:39 PM
   421   422   423   424   425   426   427   428   429   430   431